中国2型糖尿病患者应用门冬胰岛素30与甘精胰岛素的成本-效果分析
Cost-Effectiveness Analysis of Insulin Aspart 30 Versus Insulin Glargine in Patients with Type 2 Diabetes in China
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|